12,200 Shares in UiPath Inc. (NYSE:PATH) Acquired by Asahi Life Asset Management CO. LTD.

Asahi Life Asset Management CO. LTD. purchased a new position in shares of UiPath Inc. (NYSE:PATHFree Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 12,200 shares of the healthcare company’s stock, valued at approximately $303,000.

Several other large investors have also made changes to their positions in PATH. Principal Financial Group Inc. boosted its position in UiPath by 3.9% in the third quarter. Principal Financial Group Inc. now owns 42,529 shares of the healthcare company’s stock valued at $728,000 after buying an additional 1,586 shares in the last quarter. Private Advisor Group LLC acquired a new stake in UiPath in the third quarter valued at approximately $171,000. Victory Capital Management Inc. boosted its position in UiPath by 11.2% in the third quarter. Victory Capital Management Inc. now owns 45,240 shares of the healthcare company’s stock valued at $774,000 after buying an additional 4,554 shares in the last quarter. Kestra Private Wealth Services LLC boosted its position in UiPath by 67.0% in the third quarter. Kestra Private Wealth Services LLC now owns 41,121 shares of the healthcare company’s stock valued at $704,000 after buying an additional 16,493 shares in the last quarter. Finally, Spire Wealth Management boosted its position in UiPath by 251.9% in the third quarter. Spire Wealth Management now owns 17,594 shares of the healthcare company’s stock valued at $301,000 after buying an additional 12,594 shares in the last quarter. Institutional investors and hedge funds own 62.50% of the company’s stock.

Analyst Ratings Changes

PATH has been the topic of a number of research analyst reports. Wells Fargo & Company cut their target price on shares of UiPath from $25.00 to $15.00 and set an “equal weight” rating on the stock in a research report on Thursday, May 30th. Scotiabank dropped their price target on shares of UiPath from $30.00 to $25.00 and set a “sector perform” rating for the company in a research note on Wednesday, May 29th. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $29.00 price target on shares of UiPath in a research note on Monday, April 1st. BMO Capital Markets dropped their price target on shares of UiPath from $28.00 to $14.00 and set a “market perform” rating for the company in a research note on Monday, June 3rd. Finally, TD Cowen reaffirmed a “hold” rating and set a $17.00 price target (down previously from $28.00) on shares of UiPath in a research note on Thursday, May 30th. Sixteen equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $18.12.

Check Out Our Latest Stock Analysis on UiPath

Insider Buying and Selling at UiPath

In other UiPath news, CFO Ashim Gupta sold 40,000 shares of UiPath stock in a transaction on Thursday, April 4th. The shares were sold at an average price of $21.66, for a total value of $866,400.00. Following the completion of the sale, the chief financial officer now directly owns 660,762 shares of the company’s stock, valued at $14,312,104.92. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Over the last ninety days, insiders sold 96,000 shares of company stock valued at $2,023,440. Corporate insiders own 22.37% of the company’s stock.

UiPath Price Performance

NYSE PATH traded down $0.25 during mid-day trading on Friday, reaching $12.00. 13,496,576 shares of the stock were exchanged, compared to its average volume of 15,195,349. UiPath Inc. has a one year low of $11.53 and a one year high of $27.87. The stock has a market cap of $6.83 billion, a P/E ratio of -75.00 and a beta of 0.85. The stock has a 50 day simple moving average of $18.84 and a 200-day simple moving average of $21.81.

UiPath (NYSE:PATHGet Free Report) last posted its quarterly earnings results on Wednesday, March 13th. The healthcare company reported $0.06 earnings per share for the quarter, beating the consensus estimate of ($0.04) by $0.10. UiPath had a negative net margin of 6.41% and a negative return on equity of 2.97%. The firm had revenue of $405.25 million during the quarter, compared to the consensus estimate of $383.32 million. Sell-side analysts anticipate that UiPath Inc. will post -0.2 EPS for the current fiscal year.

About UiPath

(Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

Featured Articles

Want to see what other hedge funds are holding PATH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UiPath Inc. (NYSE:PATHFree Report).

Institutional Ownership by Quarter for UiPath (NYSE:PATH)

Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.